Clinical Trial Update: By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating TPF induction chemotherapy with Nimotuzumab concurrent radiotherapy and cisplatin-based concurrent chemoradiotherapy for local…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Nimotuzumab (nimotuzumab)
• induction TPF chemotherapy

Snippet

Sponsor: Guiyang Medical University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN